Annual Cash & Cash Equivalents
$525.50 M
+$109.70 M+26.38%
December 31, 2024
Summary
- As of March 2, 2025, ZBH annual cash & cash equivalents is $525.50 million, with the most recent change of +$109.70 million (+26.38%) on December 31, 2024.
- During the last 3 years, ZBH annual cash & cash equivalents has risen by +$147.40 million (+38.98%).
- ZBH annual cash & cash equivalents is now -63.99% below its all-time high of $1.46 billion, reached on December 31, 2015.
Performance
ZBH Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$525.50 M
-$43.50 M-7.64%
December 31, 2024
Summary
- As of March 2, 2025, ZBH quarterly cash and cash equivalents is $525.50 million, with the most recent change of -$43.50 million (-7.64%) on December 31, 2024.
- Over the past year, ZBH quarterly cash and cash equivalents has dropped by -$43.50 million (-7.64%).
- ZBH quarterly cash and cash equivalents is now -94.02% below its all-time high of $8.79 billion, reached on March 31, 2015.
Performance
ZBH Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ZBH Cash And Cash Equivalents Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +26.4% | -7.6% |
3 y3 years | +39.0% | -3.6% |
5 y5 years | -14.9% | -49.6% |
ZBH Cash And Cash Equivalents Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +39.9% | -7.6% | +79.9% |
5 y | 5-year | -34.5% | +39.9% | -78.4% | +79.9% |
alltime | all time | -64.0% | -100.0% | -94.0% | +3247.1% |
Zimmer Biomet Holdings Cash And Cash Equivalents History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | $525.50 M(+26.4%) | $525.50 M(-7.6%) |
Sep 2024 | - | $569.00 M(+35.4%) |
Jun 2024 | - | $420.10 M(+6.9%) |
Mar 2024 | - | $393.00 M(-5.5%) |
Dec 2023 | $415.80 M(+10.7%) | $415.80 M(+42.3%) |
Sep 2023 | - | $292.10 M(-8.7%) |
Jun 2023 | - | $319.80 M(-3.1%) |
Mar 2023 | - | $330.20 M(-12.1%) |
Dec 2022 | $375.70 M(-0.6%) | $375.70 M(-31.1%) |
Sep 2022 | - | $545.40 M(+41.1%) |
Jun 2022 | - | $386.40 M(-11.3%) |
Mar 2022 | - | $435.80 M(+15.3%) |
Dec 2021 | $378.10 M(-52.9%) | $378.10 M(-58.9%) |
Sep 2021 | - | $919.60 M(-11.8%) |
Jun 2021 | - | $1.04 B(+43.9%) |
Mar 2021 | - | $724.30 M(-9.7%) |
Dec 2020 | $802.10 M(+29.8%) | $802.10 M(-17.1%) |
Sep 2020 | - | $967.30 M(+35.6%) |
Jun 2020 | - | $713.40 M(-70.7%) |
Mar 2020 | - | $2.43 B(+293.9%) |
Dec 2019 | $617.90 M(+13.8%) | $617.90 M(+20.6%) |
Sep 2019 | - | $512.50 M(+27.1%) |
Jun 2019 | - | $403.10 M(-31.3%) |
Mar 2019 | - | $586.80 M(+8.1%) |
Dec 2018 | $542.80 M(+3.5%) | $542.80 M(+3.5%) |
Sep 2018 | - | $524.60 M(+9.0%) |
Jun 2018 | - | $481.20 M(-72.7%) |
Mar 2018 | - | $1.77 B(+236.7%) |
Dec 2017 | $524.40 M(-17.3%) | $524.40 M(+9.1%) |
Sep 2017 | - | $480.80 M(+6.8%) |
Jun 2017 | - | $450.00 M(-56.7%) |
Mar 2017 | - | $1.04 B(+63.9%) |
Dec 2016 | $634.10 M(-56.5%) | $634.10 M(+33.4%) |
Sep 2016 | - | $475.30 M(-51.3%) |
Jun 2016 | - | $976.30 M(-2.1%) |
Mar 2016 | - | $996.80 M(-31.7%) |
Dec 2015 | $1.46 B(+34.7%) | $1.46 B(-0.5%) |
Sep 2015 | - | $1.47 B(+3.0%) |
Jun 2015 | - | $1.42 B(-83.8%) |
Mar 2015 | - | $8.79 B(+711.7%) |
Dec 2014 | $1.08 B(+0.2%) | $1.08 B(+12.0%) |
Sep 2014 | - | $967.30 M(-0.1%) |
Jun 2014 | - | $968.70 M(+9.7%) |
Mar 2014 | - | $882.70 M(-18.3%) |
Dec 2013 | $1.08 B | $1.08 B(+17.8%) |
Sep 2013 | - | $917.40 M(+29.2%) |
Jun 2013 | - | $709.90 M(+8.1%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2013 | - | $657.00 M(-25.7%) |
Dec 2012 | $884.30 M(+15.1%) | $884.30 M(+10.3%) |
Sep 2012 | - | $801.50 M(+23.1%) |
Jun 2012 | - | $651.00 M(-3.4%) |
Mar 2012 | - | $674.00 M(-12.3%) |
Dec 2011 | $768.30 M(+14.9%) | $768.30 M(+38.9%) |
Sep 2011 | - | $553.00 M(-11.4%) |
Jun 2011 | - | $624.10 M(+8.4%) |
Mar 2011 | - | $575.60 M(-13.9%) |
Dec 2010 | $668.90 M(-3.3%) | $668.90 M(-29.9%) |
Jun 2010 | - | $953.70 M(+16.1%) |
Mar 2010 | - | $821.20 M(+18.7%) |
Dec 2009 | $691.70 M(+225.4%) | $691.70 M(+57.3%) |
Sep 2009 | - | $439.70 M(+58.5%) |
Jun 2009 | - | $277.50 M(+30.4%) |
Mar 2009 | - | $212.80 M(+0.1%) |
Dec 2008 | $212.60 M(-54.2%) | $212.60 M(-60.8%) |
Sep 2008 | - | $542.40 M(+39.8%) |
Jun 2008 | - | $388.10 M(-18.5%) |
Mar 2008 | - | $476.00 M(+2.6%) |
Dec 2007 | $463.90 M(+74.6%) | $463.90 M(+48.2%) |
Sep 2007 | - | $313.00 M(-12.7%) |
Jun 2007 | - | $358.70 M(+10.0%) |
Mar 2007 | - | $326.00 M(+22.7%) |
Dec 2006 | $265.70 M(+13.9%) | $265.70 M(-3.6%) |
Sep 2006 | - | $275.60 M(-17.9%) |
Jun 2006 | - | $335.80 M(-16.8%) |
Mar 2006 | - | $403.80 M(+73.2%) |
Dec 2005 | $233.20 M(+50.8%) | $233.20 M(+154.0%) |
Sep 2005 | - | $91.80 M(+16.5%) |
Jun 2005 | - | $78.80 M(+38.2%) |
Mar 2005 | - | $57.00 M(-63.1%) |
Dec 2004 | $154.60 M(+99.5%) | $154.60 M(+241.3%) |
Sep 2004 | - | $45.30 M(-41.1%) |
Jun 2004 | - | $76.90 M(-29.3%) |
Mar 2004 | - | $108.70 M(+40.3%) |
Dec 2003 | $77.50 M(+393.6%) | $77.50 M(-56.2%) |
Sep 2003 | - | $177.00 M(+53.9%) |
Jun 2003 | - | $115.00 M(+244.3%) |
Mar 2003 | - | $33.40 M(+112.7%) |
Dec 2002 | $15.70 M(-14.7%) | $15.70 M(-24.5%) |
Sep 2002 | - | $20.80 M(-21.2%) |
Jun 2002 | - | $26.40 M(+26.9%) |
Mar 2002 | - | $20.80 M(+13.0%) |
Dec 2001 | $18.40 M(>+9900.0%) | $18.40 M(-21.4%) |
Sep 2001 | - | $23.40 M |
Dec 2000 | $0.00 | - |
FAQ
- What is Zimmer Biomet Holdings annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Zimmer Biomet Holdings?
- What is Zimmer Biomet Holdings annual cash & cash equivalents year-on-year change?
- What is Zimmer Biomet Holdings quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Zimmer Biomet Holdings?
- What is Zimmer Biomet Holdings quarterly cash and cash equivalents year-on-year change?
What is Zimmer Biomet Holdings annual cash & cash equivalents?
The current annual cash & cash equivalents of ZBH is $525.50 M
What is the all time high annual cash & cash equivalents for Zimmer Biomet Holdings?
Zimmer Biomet Holdings all-time high annual cash & cash equivalents is $1.46 B
What is Zimmer Biomet Holdings annual cash & cash equivalents year-on-year change?
Over the past year, ZBH annual cash & cash equivalents has changed by +$109.70 M (+26.38%)
What is Zimmer Biomet Holdings quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ZBH is $525.50 M
What is the all time high quarterly cash and cash equivalents for Zimmer Biomet Holdings?
Zimmer Biomet Holdings all-time high quarterly cash and cash equivalents is $8.79 B
What is Zimmer Biomet Holdings quarterly cash and cash equivalents year-on-year change?
Over the past year, ZBH quarterly cash and cash equivalents has changed by -$43.50 M (-7.64%)